Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose
- PMID: 12867646
- DOI: 10.1099/vir.0.19050-0
Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose
Abstract
After passive transfer of measles virus (MV)-specific antibodies, vaccine-induced seroconversion and subsequent protection is inhibited in cotton rats (Sigmodon hispidus). In this system, an attenuated, recombinant vesicular stomatitis virus expressing the MV haemagglutinin (VSV-H) was found previously to induce neutralizing antibodies and protection against MV challenge after intranasal (i.n.) immunization. Here it is demonstrated that, after i.n. immunization, VSV-H is found in both lung and brain tissue in the absence of clinical signs. Intratracheal inoculation, which does not lead to infection of the brain, proved that immunization via the lung mucosa is sufficient to protect. To reduce or eliminate infection of the brain after i.n. inoculation, stepwise-attenuated VSV-H mutants with truncated cytoplasmic tails of the G protein were tested in cotton rats. A mutant with 9 aa in the G cytoplasmic tail was found at much lower levels in the brain and was protective in the absence or presence of MV-specific antibodies. A more attenuated mutant containing only 1 aa in its tail was not found in brain tissue after inoculation, but it still induced protective antibody to measles in the absence of MV-specific antibody. However, its ability to induce MV-neutralizing antibodies in the presence of passively transferred MV-specific antibodies and its protective capacity was abolished unless higher-dose immunizations were used. This study demonstrates that a lower degree of attenuation is required to be able to immunize in the presence of MV-specific antibodies.
Similar articles
-
Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.J Virol. 2000 May;74(10):4652-7. doi: 10.1128/jvi.74.10.4652-4657.2000. J Virol. 2000. PMID: 10775601 Free PMC article.
-
Studying experimental measles virus vaccines in the presence of maternal antibodies in the cotton rat model (Sigmodon hispidus).Vaccine. 2001 Mar 21;19(17-19):2250-3. doi: 10.1016/s0264-410x(00)00454-0. Vaccine. 2001. PMID: 11257342
-
Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.J Virol. 2003 May;77(9):5209-17. doi: 10.1128/jvi.77.9.5209-5217.2003. J Virol. 2003. PMID: 12692223 Free PMC article.
-
Cotton rats (Sigmodon hispidus): an animal model to study the pathogenesis of measles virus infection.Immunol Lett. 1999 Jan;65(1-2):47-50. doi: 10.1016/s0165-2478(98)00123-0. Immunol Lett. 1999. PMID: 10065626 Review.
-
Current animal models: cotton rat animal model.Curr Top Microbiol Immunol. 2009;330:89-110. doi: 10.1007/978-3-540-70617-5_5. Curr Top Microbiol Immunol. 2009. PMID: 19203106 Review.
Cited by
-
Newcastle Disease Virus as a Vaccine Vector for 20 Years: A Focus on Maternally Derived Antibody Interference.Vaccines (Basel). 2020 May 14;8(2):222. doi: 10.3390/vaccines8020222. Vaccines (Basel). 2020. PMID: 32422944 Free PMC article. Review.
-
Rhabdoviruses as vectors for vaccines and therapeutics.Curr Opin Virol. 2020 Oct;44:169-182. doi: 10.1016/j.coviro.2020.09.003. Epub 2020 Oct 29. Curr Opin Virol. 2020. PMID: 33130500 Free PMC article. Review.
-
Nonsegmented negative-strand viruses as vaccine vectors.J Virol. 2006 Nov;80(21):10293-306. doi: 10.1128/JVI.00919-06. J Virol. 2006. PMID: 17041210 Free PMC article. Review. No abstract available.
-
Synergistic induction of interferon α through TLR-3 and TLR-9 agonists stimulates immune responses against measles virus in neonatal cotton rats.Vaccine. 2014 Jan 3;32(2):265-70. doi: 10.1016/j.vaccine.2013.11.013. Epub 2013 Nov 18. Vaccine. 2014. PMID: 24262312 Free PMC article.
-
SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector.Virology. 2008 Jun 20;376(1):165-72. doi: 10.1016/j.virol.2008.03.002. Epub 2008 Apr 8. Virology. 2008. PMID: 18396306 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical